General
impact 24
New NIST Reference Material to Strengthen Quality Control for Biological Drugs
New NIST Reference Material to Strengthen Quality Control for Biological Drugs Impurities in these drugs can cause undesirable immune responses in patients and can significantly drive up costs for drug manufacturers.
Why it matters
The drugs angle matters most here. If confirmed, expect ripple effects across nist and related sectors.